PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Henke, C. ; Töllner, K.* ; van Dijk, R.M.* ; Miljanovic, N.* ; Cordes, T.* ; Twele, F.* ; Bröer, S.* ; Ziesak, V.* ; Rohde, M.* ; Hauck, S.M. ; Vogel, C.* ; Welzel, L.* ; Schumann, T. ; Willmes, D.M. ; Kurzbach, A. ; El-Agroudy, N.N. ; Bornstein, S.R.* ; Schneider, S.A.* ; Jordan, J.* ; Potschka, H.* ; Metallo, C.M.* ; Köhling, R.* ; Birkenfeld, A.L. ; Löscher, W.*

Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.

Neurobiol. Dis. 143:105018 (2020)
Postprint Forschungsdaten DOI
Open Access Hybrid
Creative Commons Lizenzvertrag
In addition to tissues such as liver, the plasma membrane sodium-dependent citrate transporter, NaCT (SLC13A5), is highly expressed in brain neurons, but its function is not understood. Loss-of-function mutations in the human SLC13A5 gene have been associated with severe neonatal encephalopathy and pharmacoresistant seizures. The molecular mechanisms of these neurological alterations are not clear. We performed a detailed examination of a Slc13a5 deletion mouse model including video-EEG monitoring, behavioral tests, and electrophysiologic, proteomic, and metabolomic analyses of brain and cerebrospinal fluid. The experiments revealed an increased propensity for epileptic seizures, proepileptogenic neuronal excitability changes in the hippocampus, and significant citrate alterations in the CSF and brain tissue of Slc13a5 deficient mice, which may underlie the neurological abnormalities. These data demonstrate that SLC13A5 is involved in brain citrate regulation and suggest that abnormalities in this regulation can induce seizures. The present study is the first to (i) establish the Slc13a5-knockout mouse model as a helpful tool to study the neuronal functions of NaCT and characterize the molecular mechanisms by which functional deficiency of this citrate transporter causes epilepsy and impairs neuronal function; (ii) evaluate all hypotheses that have previously been suggested on theoretical grounds to explain the neurological phenotype of SLC13A5 mutations; and (iii) indicate that alterations in brain citrate levels result in neuronal network excitability and increased seizure propensity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.332
1.231
10
18
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Epilepsy, Nact ; Proteom ; Metabolom ; Parahippocampal Cortex; Affinity Zinc Inhibition; Rat Model Focus; Primary Cultures; Pyruvate Carboxylation; Coupled Dicarboxylate; Insulin-resistance; Status Epilepticus; Mouse Model; Seizures; Epilepsy
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 0969-9961
e-ISSN 1095-953X
Zeitschrift Neurobiology of Disease
Quellenangaben Band: 143, Heft: , Seiten: , Artikelnummer: 105018 Supplement: ,
Verlag Elsevier
Verlagsort 525 B St, Ste 1900, San Diego, Ca 92101-4495 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
CF Metabolomics & Proteomics (CF-MPC)
POF Topic(s) 90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-502600-012
G-505700-001
A-630700-001
DOI 10.1016/j.nbd.2020.105018
WOS ID WOS:000556567000025
Scopus ID 85088141529
Erfassungsdatum 2020-10-01
[➜Korrektur melden]